Similarly, ALL blasts isolated from the BM of our recently described KMT2Ar infant ALL (CRISPRKMT2A-AFF1 ALL)32 demonstrated variable expression of CD133, and minimal expression of CD1d on CD19+ blasts (supplemental Figure 1A-B). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.